CRP and cancer: Most published studies revealed that various inflammatory markers, such as NEU, MON, LYM, PLT, and CRP, play a very important role in promoting metastasis of cancer cells, increasing vascular proliferation and permeability, regulating cancer progression and metastasis, promoting immune surveillance, and antitumor immune response (36–39).